ADMA Biologics (ADMA) Q3 2026 Earnings Call Transcript
ASCENIV demand surged while BIVIGAM faced pressure, and receivables lagged the target range.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
ASCENIV demand surged while BIVIGAM faced pressure, and receivables lagged the target range.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Reactions have continued to trail the attack on the presidential campaign convoy of the African Democratic Congress, ADC, by suspected political thugs during a rally in Kebbi State on Thursday.
More than £2trillion was wiped off the value of the Nasdaq as a tech rout fuelled fears of a stock market crash - and left Elon Musk nursing billions of pounds of losses.
Record trailing profits lifted Virtu despite cooling market volatility.
Postpaid migration and a Colombia 5G build-out headline the call.